GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company...
Funding will support planned Phase 1b anti-viral study in patients with mild to moderate COVID-19 infectionsSAN DIEGO, May 04, 2021...
SOUTH SAN FRANCISCO, Calif. and HANOVER, Md., May 04, 2021 (GLOBE NEWSWIRE) -- In recognition of World Sickle Cell Day,...
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene...
- ARCALYST® (rilonacept) launched as the first and only FDA-approved therapy for recurrent pericarditis -- Mavrilimumab Phase 2 severe COVID-19...
Panel Discussion and Presentation part of Future of Cell and Gene Therapies EventBOSTON, May 04, 2021 (GLOBE NEWSWIRE) -- Ziopharm...
VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (CSE: TRUE), a disruptive healthcare technology company that...
Study will evaluate safety and immunogenicity of multiple distinct dosing regimens of norovirus oral vaccine candidate Norovirus infects 15% of...
Webinar on Thursday, May 13th @ 1pm ETCARLSBAD, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI),...
ESKAPE Pathogens: Standardised and Drug Resistant Broad Efficacious Dosing Range Figure 1 Minimum inhibitory concentration (ppm) of RECCE® 327 against...
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to...
Results allow the Company to advance development, including planning for its multiple-ascending dose clinical studyREDWOOD CITY, Calif., May 04, 2021...
EAGLE, Idaho, May 04, 2021 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries...
NEW YORK, May 04, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and...
Data showed reduction of neovascular lesion formation and vascular leakage in a rodent model of choroidal neovascularizationABP201 performed equally or...
BOSTON, May 04, 2021 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (NASDAQ: YMTX), a biopharmaceutical company focused on the development of innovative,...
Ann Cunningham has a proven pharmaceutical commercial track record of more than 25 years delivering sales, marketing, and global life...
Hosted conference call to begin at 4:30 p.m. ETNEW YORK, May 04, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”)...
LONDON and REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or “the...
-Data from studies of novel AAV vectors and AAV immunology and an encore of 12-month safety, efficacy and patient-reported outcomes...